These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22996451)

  • 1. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
    Di Zenzo G; Di Lullo G; Corti D; Calabresi V; Sinistro A; Vanzetta F; Didona B; Cianchini G; Hertl M; Eming R; Amagai M; Ohyama B; Hashimoto T; Sloostra J; Sallusto F; Zambruno G; Lanzavecchia A
    J Clin Invest; 2012 Oct; 122(10):3781-90. PubMed ID: 22996451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
    Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
    J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
    Payne AS; Ishii K; Kacir S; Lin C; Li H; Hanakawa Y; Tsunoda K; Amagai M; Stanley JR; Siegel DL
    J Clin Invest; 2005 Apr; 115(4):888-99. PubMed ID: 15841178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity.
    Tavakolpour S; Noormohammadi Z; Daneshpazhooh M; Gholami A; Mahmoudi H
    Front Immunol; 2024; 15():1469937. PubMed ID: 39416775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
    Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
    J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients.
    Qian Y; Diaz LA; Ye J; Clarke SH
    J Immunol; 2007 May; 178(9):5982-90. PubMed ID: 17442983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients.
    Cho MJ; Lo AS; Mao X; Nagler AR; Ellebrecht CT; Mukherjee EM; Hammers CM; Choi EJ; Sharma PM; Uduman M; Li H; Rux AH; Farber SA; Rubin CB; Kleinstein SH; Sachais BS; Posner MR; Cavacini LA; Payne AS
    Nat Commun; 2014 Jun; 5():4167. PubMed ID: 24942562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris.
    Kugelmann D; Anders M; Sigmund AM; Egu DT; Eichkorn RA; Yazdi AS; Sárdy M; Hertl M; Didona D; Hashimoto T; Waschke J
    Front Immunol; 2022; 13():884248. PubMed ID: 35844545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting pemphigus autoantibodies through their heavy-chain variable region genes.
    Payne AS; Siegel DL; Stanley JR
    J Invest Dermatol; 2007 Jul; 127(7):1681-91. PubMed ID: 17392832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.